These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A phase II trial using thalidomide for Langerhans cell histiocytosis. McClain KL; Kozinetz CA Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818 [TBL] [Abstract][Full Text] [Related]
26. [Frequency of hearing disorders in children with langerhans' cell histiocytosis]. Kürten T; Groeger M; Angerstein W Laryngorhinootologie; 2008 Feb; 87(2):96-9. PubMed ID: 18214817 [TBL] [Abstract][Full Text] [Related]
27. Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan. Morimoto A; Shioda Y; Imamura T; Kanegane H; Sato T; Kudo K; Nakagawa S; Nakadate H; Tauchi H; Hama A; Yasui M; Nagatoshi Y; Kinoshita A; Miyaji R; Anan T; Yabe M; Kamizono J; Pediatr Blood Cancer; 2011 Jan; 56(1):110-5. PubMed ID: 21108445 [TBL] [Abstract][Full Text] [Related]
28. High dose immunoglobulin (IVIG) may reduce the incidence of Langerhans cell histiocytosis (LCH)-associated central nervous system involvement. Imashuku S CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):380-6. PubMed ID: 19702569 [TBL] [Abstract][Full Text] [Related]
29. Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study. Idbaih A; Donadieu J; Barthez MA; Geissmann F; Bertrand Y; Hermine O; Brugières L; Genereau T; Thomas C; Hoang-Xuan K Pediatr Blood Cancer; 2004 Jul; 43(1):55-8. PubMed ID: 15170890 [TBL] [Abstract][Full Text] [Related]
30. Hungarian experience with Langerhans cell histiocytosis in childhood. Müller J; Garami M; Hauser P; Schuler D; Csóka M; Kovács G; Rényi I; Kovács G; Marosi A; Galántai I; Békési A; Kajtár P; Kiss CS; Nagy K; Bartyik K; Masáth P; Kriván G; Pediatr Hematol Oncol; 2006 Mar; 23(2):135-42. PubMed ID: 16651242 [TBL] [Abstract][Full Text] [Related]
31. Histiocytic syndromes in children. Cetingül N; Oztop S; Kavakli K; Ozunan I; Nişli G; Hekimgil M Turk J Pediatr; 1997; 39(3):287-94. PubMed ID: 9339106 [TBL] [Abstract][Full Text] [Related]
32. Long-term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow-up of the JLSG-96/02 studies. Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S; Br J Haematol; 2021 Feb; 192(3):615-620. PubMed ID: 33236384 [TBL] [Abstract][Full Text] [Related]
33. Langerhans cell histiocytosis in children less than 2 years of age. Kusuma Kumary P; Priyakumari T; Chellam VG; James FV; Nair MK Indian Pediatr; 1999 Jan; 36(1):29-36. PubMed ID: 10709120 [TBL] [Abstract][Full Text] [Related]
34. Use of indomethacin in Langerhans cell histiocytosis. Munn SE; Olliver L; Broadbent V; Pritchard J Med Pediatr Oncol; 1999 Apr; 32(4):247-9. PubMed ID: 10102016 [TBL] [Abstract][Full Text] [Related]
35. Combined central and peripheral demyelination: comparison of adult and pediatric series. Ravaglia S; Tavazzi E; Moglia A; Ceroni M; Marchioni E Pediatr Neurol; 2009 Jul; 41(1):77; author reply 77-8. PubMed ID: 19520285 [No Abstract] [Full Text] [Related]
36. Intralesional infiltration of corticosteroids in the treatment of localised langerhans' cell histiocytosis of the mandible Report of known cases and three new cases. Putters TF; de Visscher JG; van Veen A; Spijkervet FK Int J Oral Maxillofac Surg; 2005 Jul; 34(5):571-5. PubMed ID: 16053880 [TBL] [Abstract][Full Text] [Related]